von Willebrand Disease in Pediatrics

This article reviews these recent advances, as well as currently available treatment options, including desmopressin, antifibrinolytics, and both plasma-based and recombinant von Willebrand factor products. The diagnosis of VWD remains complex and this article provides an understanding of the various subtypes and phenotypes of VWD, as well as the appropriateness and interpretation of the many available laboratory tests.

Source: Hematology/Oncology Clinics of North America - April 26, 2019 Category: Cancer & Oncology Authors: Sarah H. O ’Brien, Surbhi Saini Source Type: research